Navigation Links
UC San Diego Clinical Trials for Latin America International Seminar at Hospital Angeles in Tijuana
Date:11/7/2011

d it certainly represents an affordable solution for multi-site clinical studies.

"We are also thrilled now to partner with the Hospital Angeles group with the goal of updating the knowledge base among their health personnel interested in clinical trials," affirms Villa-Caballero.

Hospital Angeles group (HA) is the largest private hospital network in Mexico. It includes approximately twenty top-of-the-line hospitals in the most important cities across Mexico. HA group, with approximately 2,500 physicians in its network, represents a role model of modern and high quality medicine in Latin America. In 2006, Hospital Angeles launched a branch in Tijuana and has attracted many talented physicians and health professionals from the Baja California region.

"There are many well prepared clinical researchers and physicians from our group looking to become principal investigators or participate in multisite-clinical trials," states HA Tijuana Medical Director Cesar Amescua, MD. "At the same time, there is a clear perception of the need for educational programs in clinical trials to fulfill the demand of knowledge in this field. The certificate offered by UC San Diego Extension appeared at the perfect time for our academic growth."

A selected HA group of professionals attended the live workshop in San Diego offered last May.

"I discussed with HA education leaders the benefits of this program for my staff and we want to make this program available to the rest of our medical group and to other HA physicians from other sites in Mexico as well," concludes Amescua.

The seminar will be hosted by HA medical leaders and the agenda includes a lecture with preliminary results of a phase 1 study currently performed by Amescua, a lecture on angiotensin in translational medicine by Laurence Brunton, PhD, UC San Diego pharmacology professor and a presentation of the certificate program in clinical trials by Villa-Caballero.

Media contact:
'/>"/>

SOURCE University of California San Diego Extension
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Latest Health and Wellness In-Car Technology from Ford to be Showcased Oct. 10-13 in San Diego
2. Local School Nurses Unite Community to Combat Low Meningitis Vaccination Rates Among Preteens and Teens in San Diego
3. MacroGenics Announces Presentation of Protege Phase 3 Clinical Data at ADA in San Diego on June 28
4. Health Information Technology: UC San Diego New Seminar Explores Four Critical Issues
5. Millennium Laboratories Founder and CEO James Slattery Named Ernst & Young Entrepreneur of the Year® San Diego Finalist
6. Millennium Laboratories Founder and CEO James Slattery Named Ernst & Young Entrepreneur Of The Year® 2011 Award Semifinalist in San Diego
7. Awarepoint CTO, Matt Perkins, to Serve as Panelist at CommNexus San Diego Event
8. Thomas, McNerney & Partners Expands Team and Moves West Coast Office to San Diego
9. TLC Vision Announces TLC Laser Eye Center San Diego
10. Surgeons at University of California San Diego Perform 1st TRAM Flap Procedure in an International Multi-Center Study Using TIGR® Matrix Surgical Mesh, the Worlds 1st Long-Term Resorbable Mesh
11. BD and Rady Childrens Hospital-San Diego Announce Innovative Pilot Project to Reduce Environmental Impact of Sharps Disposal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... -- Releases of the genetically engineered Oxitec ... , , reduced the dengue mosquito population in an ... 95%, well below the modelled threshold for epidemic disease ... The journal PLOS Neglected Tropical Diseases published today the ... The results showed that in Juazeiro city, northeast ...
(Date:7/2/2015)... LAKEWAY, Texas , July 2, 2015   ... on being the leading provider for non-invasive aesthetics in ... offer state-of-the-art tattoo removal treatments with the Astanza Duality ... transform their well being through various medical and laser ... patients with unwanted ink a clear solution to their ...
(Date:7/2/2015)... and DURHAM, N.C. , July 2, ... announced its acquisition of assets related to the ion ... ) that had previously been obtained as part of ... acquired all of Pfizer,s rights to the "Icagen" name ... and will provide comprehensive services for ion channel and ...
Breaking Medicine Technology:Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 2Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 3EVO Offers Advanced Laser Tattoo Removal With Astanza Duality In Lakeway, TX 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 3Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 4
... Bayer HealthCare Pharmaceuticals was handed a pounding $100 ... unlikely to relieve.  The law firm of Sanford Wittels ... U.S. District Court for New Jersey, citing instances of ... employees at Novartis Pharmaceuticals who successfully won a jury ...
... 2011 Beginning April 1, Highmark Blue Cross Blue ... patients with primary immunodeficiency diseases and other rare disorders ... immunoglobulin (IgG - a blood plasma product), regardless of ... even patients who are being treated successfully with another ...
Cached Medicine Technology:Bayer Gets $100M Gender Class Action Headache 2Bayer Gets $100M Gender Class Action Headache 3Bayer Gets $100M Gender Class Action Headache 4Despite New Changes, Highmark Policy Still Threatens Patients With Primary Immunodeficiency Diseases 2Despite New Changes, Highmark Policy Still Threatens Patients With Primary Immunodeficiency Diseases 3
(Date:7/2/2015)... Spring, Md. (PRWEB) , ... July 02, 2015 , ... ... mark in his solo cross-country walk to raise awareness and money for the ... and expects to arrive at PHA’s headquarters near Washington, D.C. by mid-September. He left ...
(Date:7/2/2015)... ... ... ActiveBunch.com recently launched as a social network created for people with an ... community, Active Bunch allows users to connect with like-minded fitness enthusiasts from around the ... group events. , The spokesperson for Active Bunch explained the idea behind the ...
(Date:7/2/2015)... (PRWEB) , ... July 02, ... ... wound therapy (NPWT) - pipeline review 2015” provides comprehensive information on the ... development. Complete report on negative pressure wound therapy (NPWT) with 22 market ...
(Date:7/2/2015)... Jeffersonville, Pennsylvania (PRWEB) , ... ... ... nation’s largest e-commerce janitorial supply company , announced today that it ... Commercial Products. The acquisition will make CleanItSupply.com the largest distributor of Rubbermaid ...
(Date:7/2/2015)... OK (PRWEB) , ... July 02, 2015 , ... Real Time Pain Relief ... reached an agreement with Big Sky PBR to sponsor The Fifth Annual Big ... Time Pain Relief will offer product samples of their popular pain relief lotion and products ...
Breaking Medicine News(10 mins):Health News:79-Year-old ‘Pacing Parson’ Passes 1,000-Mile Mark in Cross-Country Walk for Pulmonary Hypertension Association 2Health News:79-Year-old ‘Pacing Parson’ Passes 1,000-Mile Mark in Cross-Country Walk for Pulmonary Hypertension Association 3Health News:ActiveBunch.com Launches as a Social Community for People with Active Lifestyles 2Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:CleanItSupply.com Acquires eRubbermaid.com 2Health News:Real Time Pain Relief Sponsors The Fifth Annual Big Sky Professional Bull Riders Event at Big Sky Town Center in July 2Health News:Real Time Pain Relief Sponsors The Fifth Annual Big Sky Professional Bull Riders Event at Big Sky Town Center in July 3
... Perrigo Company,(Nasdaq: PRGO ; TASE) today announced ... Food and Drug Administration to manufacture and market,Ciclopirox ... The product has been determined to be ... Nail Lacquer, indicated for the,treatment of mild to ...
... Study Data Demonstrated Improved Progression-free Survival with Campath, ... ,Genzyme Corp. (Nasdaq: GENZ ) and Bayer ... that the U.S. Food and Drug Administration,(FDA) has ... (alemtuzumab) and granted regular approval for single-agent,Campath for ...
... Pa., Sept. 21 Cephalon, Inc. (Nasdaq:,CEPH) today ... Application (NDA) to,the U.S. Food and Drug Administration ... treatment of patients with chronic,lymphocytic leukemia (CLL). CLL ... with an estimated 15,000 new cases diagnosed every ...
... grains for breakfast, such as whole-grain barley or rye, ... breakfast, lunch, and dinner. It was previously not known ... This is due to a combination of low GI ... occur in certain grain products. The findings are presented ...
... study by researchers at the University of Southern California suggests ... Researchers found that a storyline on the primetime NBC network ... eating habits had a positive impact on the attitudes and ... in the Sept. 14 Journal of Health Communication and now ...
... Insights might produce treatments to kill off cancer cells, ... New information about a process called unplanned cell death, ... disease, cancer, stroke and other life-threatening conditions, scientists say. ... natural, healthy programmed cell death. Necrosis is an unplanned ...
Cached Medicine News:Health News:Perrigo Company Announces FDA Approval for Ciclopirox Topical Solution 2Health News:FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia 2Health News:FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia 3Health News:FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia 4Health News:FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia 5Health News:FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia 6Health News:Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia 2Health News:Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia 3Health News:Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia 4Health News:Right breakfast bread keeps blood sugar in check all day 2Health News:ER episode impacts viewers' health knowledge and behavior 2Health News:Clues to Cell Death Could Fight Disease 2
Bone removing chisel for decortication of lumbar vertebral bodies....
Rasp with down cutting pattern....
9 inch sharp bone hook with grip handle....
Lewin Bone Forceps, serrated and slightly curved. To hold, stabilize, rotate, reduce and,compress bone....
Medicine Products: